Two extremely low birthweight (ELBW) infants developed airway obstruction while being treated with oxygen cannulas. We have previously shown that nasal mucosal injury from use of oxygen cannulas in ELBW infants increases nasal secretions and bleeding. Airway patency may be compromised when ELBW infants are treated with oxygen cannulas.
INTRODUCTION
Since newborn infants are obligate nose breathers, they are at risk for developing upper airway obstruction if their nasal passages become narrowed or occluded. 1, 2 We have shown that use of oxygen cannulas (OCs) in extremely low birthweight (ELBW) infants injures their nasal mucosa. 3 The mucosal injury is manifested as an increase in nasal secretions requiring more frequent suctioning by the caretakers, and by an increased rate of visible blood in the infants' nasal secretions. 3 We report here two ELBW infants who developed severe upper airway obstruction while being treated with OCs.
CASE REPORTS Infant 1
A 956-g, 27-week gestation infant was treated for RDS, PDA, and hypotension. She was extubated on hospital day 34 and placed on an oxygen cannula (OC). After 15 days, the infant was noted to be in respiratory distress with deep substernal retractions and poor air entry. On examination, there was marked edema of the nasal mucosal and noisy breathing was heard with a stethoscope placed under the nares. Partial obstruction of the nares was diagnosed. The OC was removed, and the infant was placed under an oxygen hood and given four doses of dexamethasone, 0.25 mg/kg, at 12-hour intervals. Within 2 days, the respiratory distress had completely resolved and the infant weaned from oxygen.
Infant 2
A 990-g, 29-week gestation infant was treated for RDS and PDA. On hospital day 31, 9 days after being placed on an OC, she developed severe subcostal retractions, poor air entry, and respiratory acidosis with Pco 2 87, pH 7.15. Noisy respirations were heard with a stethoscope held under the infant's nose. At this time, a suction catheter could not be passed through the infant's right nare because of mucosal edema, and a nasogastric tube was in place in the left nare. As soon as the nasogastric tube and OC were removed and the infant placed under an oxygen hood, her respirations became unlabored, and 2 hours later a repeat blood gas was normal. The infant was weaned from oxygen over the next 48 hours.
DISCUSSION
Since newborn infants are obligate nose breathers, they are at risk for developing upper airway obstruction if their nasal passages become narrowed or occluded. 1, 2 We have shown that use of OCs in ELBW infants injures the nasal mucosa manifested by an increase in nasal secretions requiring more frequent suctioning and an increased rate of visible blood in the infants' nasal secretions. 3 In this report, we describe two ELBW infants who developed severe upper airway obstruction while being treated with OCs.
Nares obstruction presented in both infants with respiratory distress, subcostal retractions and markedly diminished breath sounds. In both, noisy breathing was easily detected by auscultation while holding the stethoscope bell beneath the infants' nares. In the second infant with documented respiratory acidosis, nasal obstruction was so severe that it was impossible to pass a suction catheter through the infant's right nare.
While mucosal edema, secretions, or bleeding will increase airway resistance in any patient, the resulting airway obstruction is more serious in newborn infants as they are obligate nose breathers. Failure of the infants to breath through their mouths when their nasal passages become narrowed may lead to critically elevated airway resistance and clinical worsening in respiratory status. Also, since the nares of ELBW infants are smaller and their tissues are more delicate than in larger infants, they are likely more vulnerable to nasal mucosal trauma and erosion from use of OCs than are larger preterm or term infants. The small cross-sectional diameter of their nares also makes ELBW infants especially vulnerable to nares obstruction as, with laminar gas flow, resistance varies inversely with the radius of the airway raised to the fourth power. Even partial nasal obstruction will significantly increase work of breathing as nasal resistance accounts for up to 50% of total lung resistance in newborn infants. 4 While nares obstruction was apparently solely because of mucosal injury, which occurred from use of an OC in the first infant, siting of a nasogastric tube appeared to be a contributing factor in the second infant. It has been shown that placement of a nasogastric tube may double airway resistance in premature infants. 5 Use of an indwelling nasogastric tube would therefore put a premature infant at a greater risk for nares obstruction if nasal mucosal edema, secretions, or bleeding occur. The infant's respiratory distress resolved when the feeding tube was removed, showing that it played a role in causing critical airway obstruction when mucosal edema and secretions obstructed the infant's other nare.
In addition to increasing work of breathing, airway obstruction can result in decreased tidal and minute ventilation, periodic breathing, and apnea spells. 6, 7 These are common problems occurring in many small premature infants, so the role of nares obstruction in causing periodic breathing or apnea spells as well as increased respiratory effort might easily be overlooked.
Prevention of nasal obstruction from use of OCs is clearly preferable to treating it. Hopefully, the techniques used for administering nasal oxygen and for suctioning the nares can be modified to avoid nasal mucosal injury. Once severe nasal obstruction has developed, the OC should be removed as should a nasogastric tube if it is contributing to airway obstruction. It is possible that locally acting vasoconstricting or anti-inflammatory medications may be helpful, but we have no experience with them. Systemic steroids, as used in our first infant, cannot be recommended because of recent concerns about their safety. Use of nasal CPAP might relieve the obstruction by dilating the nares, but the nasal CPAP prongs could also potentially irritate the nasal mucosa. Some infants may require a short ventilator course while their nasal mucosa heals.
Use of OCs largely replaced oxyhoods and oxyisolettes in neonatal units because their use facilitates nursing care, and they were not considered invasive. In an accompanying report, we showed that use of high-flow OCs in ELBW infants is associated with increased nasal secretions and erosion of the nasal mucosa with bleeding. 3 The two ELBW infants reported here developed severe upper airway obstruction, which apparently resulted from OC use. Airway obstruction resulting from OC use should be considered when the respiratory status of small premature infants worsens while they are being treated with OCs. Further study is indicated to see if nasal mucosal injury can be prevented in infants being treated with OCs.
